Cargando…
Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy
Triple-negative breast cancers (TNBCs) are the most aggressive and hard-to-treat breast tumors with poor prognosis, and exploration for novel therapeutic drugs is impending. Arctigenin (Atn), a bioactive lignan isolated from seeds of Arctium lappa L, has been reported to inhibit many cancer types; h...
Autores principales: | Feng, Tingting, Cao, Wei, Shen, Wanxiang, Zhang, Liang, Gu, Xinsheng, Guo, Yang, Tsai, Hsiang-i, Liu, Xuewen, Li, Jian, Zhang, Jingxuan, Li, Shan, Wu, Fuyun, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352123/ https://www.ncbi.nlm.nih.gov/pubmed/27861147 http://dx.doi.org/10.18632/oncotarget.13393 |
Ejemplares similares
-
Arctigenin: a lignan from Arctium lappa
por: Gao, Haiyan, et al.
Publicado: (2008) -
Pharmacokinetics of Arctigenin and Fructus Arctii Powder in Piglets
por: He, Bin, et al.
Publicado: (2019) -
28-Day Oral Chronic Toxicity Study of Arctigenin in Rats
por: Tan, Yu-jun, et al.
Publicado: (2018) -
Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
por: Li, Jie, et al.
Publicado: (2019) -
Arctigenin: pharmacology, total synthesis, and progress in structure modification
por: Wu, Dan, et al.
Publicado: (2022)